Brenda J. Tromp
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study.
Journal: Leukemia & lymphoma
Published: January 03, 2023
Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: September 06, 2022
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA.
Journal: Annals of hematology
Published: August 24, 2022
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Journal: The New England journal of medicine
Published: June 30, 2021
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: June 09, 2021
A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease.
Journal: Oncotarget
Published: February 26, 2015
A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 25, 2014
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: October 18, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026